News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
575,040 Results
Type
Article (45800)
Company Profile (170)
Press Release (529070)
Section
Business (160987)
Career Advice (2423)
Deals (30110)
Drug Delivery (120)
Drug Development (72812)
Employer Resources (148)
FDA (16043)
Job Trends (12582)
News (287715)
Policy (30999)
Tag
Academia (2412)
Alliances (39986)
Alzheimer's disease (1383)
Approvals (15992)
Artificial intelligence (203)
Bankruptcy (324)
Best Places to Work (9656)
Breast cancer (226)
Cancer (1712)
Cardiovascular disease (141)
Career advice (2020)
CAR-T (133)
Cell therapy (373)
Clinical research (58699)
Collaboration (629)
Compensation (378)
COVID-19 (2706)
C-suite (166)
Data (1599)
Diabetes (224)
Diagnostics (5631)
Earnings (64585)
Employer resources (135)
Events (85571)
Executive appointments (544)
FDA (16977)
Funding (538)
Gene therapy (271)
GLP-1 (744)
Government (4028)
Healthcare (15689)
Infectious disease (2834)
Inflammatory bowel disease (120)
Interviews (450)
IPO (14573)
Job creations (3332)
Job search strategy (1685)
Layoffs (485)
Legal (7385)
Lung cancer (250)
Manufacturing (246)
Medical device (11710)
Medtech (11713)
Mergers & acquisitions (15902)
Metabolic disorders (620)
Neuroscience (1811)
NextGen: Class of 2025 (5202)
Non-profit (3483)
Northern California (2068)
Obesity (350)
Opinion (216)
Patents (179)
People (46832)
Phase I (17680)
Phase II (25494)
Phase III (20446)
Pipeline (787)
Postmarket research (2417)
Preclinical (7165)
Radiopharmaceuticals (218)
Rare diseases (346)
Real estate (4785)
Regulatory (21456)
Research institute (2203)
Resumes & cover letters (405)
Southern California (1739)
Startups (2994)
United States (17749)
Vaccines (709)
Weight loss (269)
Date
Today (80)
Last 7 days (757)
Last 30 days (2643)
Last 365 days (32113)
2025 (5159)
2024 (32707)
2023 (36633)
2022 (47104)
2021 (50937)
2020 (48328)
2019 (38667)
2018 (29299)
2017 (29401)
2016 (27834)
2015 (30930)
2014 (24431)
2013 (20239)
2012 (21859)
2011 (22328)
2010 (20589)
Location
Africa (695)
Arizona (159)
Asia (32593)
Australia (5673)
California (4639)
Canada (1387)
China (348)
Colorado (201)
Connecticut (240)
Europe (79025)
Florida (683)
Georgia (149)
Illinois (395)
Indiana (221)
Japan (122)
Maryland (729)
Massachusetts (3475)
Michigan (164)
Minnesota (290)
New Jersey (1425)
New York (1298)
North Carolina (933)
Northern California (2068)
Ohio (152)
Pennsylvania (998)
South America (1062)
Southern California (1739)
Texas (647)
Utah (125)
Washington State (443)
575,040 Results for "promethera biosciences s a n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers
February 19, 2025
·
8 min read
Press Releases
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
January 27, 2025
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
January 15, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Host Virtual R&D Update with KOL Speakers on February 18, 2025
February 11, 2025
·
4 min read
Press Releases
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease
January 14, 2025
·
10 min read
QIAGEN N.V. to release results for Q1 2024 and hold webcast
QIAGEN N.V. announced plans to release results for the first quarter 2024.
April 9, 2024
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function
December 9, 2024
·
9 min read
Genetown
Merus N.V. Announces Proposed Public Offering of Common Shares - May 28, 2024
Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares.
May 28, 2024
·
10 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease
December 10, 2024
·
13 min read
Press Releases
QIAGEN N.V. to release results for Q3 2024 and hold webcast
October 10, 2024
·
1 min read
1 of 57,504
Next
